Medications Left at Bedside Without Self-Administration Assessment
Summary
The facility failed to ensure that three sampled residents were assessed for medication self-administration before medications were left at the bedside. The facility policy stated residents may self-administer medications only when specifically authorized by the attending physician and in accordance with self-administration procedures. Review of records and observations showed no physician orders or self-administration assessments for R61, R19, or R43, and no care plans addressing medication self-administration for any of the three residents. R61 had diagnoses including legal blindness and age-related cataracts, with a BIMS score of 14. Active orders included eye medications for dry eyes, but there was no order for self-administration or bedside medications. The EMR contained no assessment showing R61 was capable of self-administration. During observation, GenTeal Tears Severe Day/Night ophthalmic gel and Artificial Tears ophthalmic solution were found on the bedside table. R61 stated he used the eye drops morning and night and that the nurse left them in the room. An LPN stated the medication should not have been left at the bedside, and another LPN stated she had left the eye drops in the room because she had to go to the bathroom and did not return to put them away. R19 had diagnoses including dementia and osteoarthritis, with a BIMS score of 7 and care plan documentation of impaired cognitive function and thought processes. The resident had an active order for Voltaren Arthritis Pain gel, but there was no physician order for self-administration. A self-administration assessment dated 1/6/2026 stated R19 was not capable of storing or self-administering medication. Despite this, diclofenac gel and a medicine cup with cream were observed on the bedside table, and an LPN confirmed the medication was present and stated the resident had not been assessed for self-administration. R43 had diagnoses including COPD and obstructive hypertrophic cardiomyopathy, with a BIMS score of 12 and care plan interventions for administering medications and puffers as ordered. Active orders included Advair HFA, azelastine nasal spray, and Proventil HFA, but there was no order or assessment for self-administration. An Advair inhaler, Proventil inhaler, and azelastine nasal spray were observed at the bedside, and R43 stated the nurses left the medications there in case she needed them. An LPN confirmed leaving the medications at the bedside and stated R43 was not assessed to safely self-administer medications.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.